Treatment of Menopausal Symptoms in Family Medicine Settings following the Women’s Health Initiative Findings

References

1. ↵
   Cheung AM, Chaudry R, Kapral M, Jackvicius C, Robinson G. Perimenopausal and postmenopausal health. BMC Women’s Health 2004; 4(Suppl 1): S23.

   OpenUrl
2. ↵
   Gracia CR, Freeman EW. Acute consequences of the menopausal transition: the rise of common menopausal symptoms. Endocrinol Metab Clin North Am 2004; 33: 675–89.

   OpenUrl
3. ↵
   Dennerstein L, Duddley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000; 96: 351–8.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   Cutson TM, Meuleman E. Managing menopause. Am Fam Physician 2000; 61: 1391–400.

   OpenUrlPubMed
5. Gorsky RD, Koplan JP, Peterson HB, Thacker SB. Relative risks and benefits of long-term estrogen replacement therapy: a decision analysis. Obstet Gynecol 1994; 83: 161–6.

   OpenUrlPubMedWeb of Science
6. ↵
   Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy. JAMA 2004; 291: 47–53.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   The Women’s Health Initiative Study Group. Design of the Women’s Health Initiative clinical trial and observational study. Control Clin Trials 1998; 19: 61–109.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative Randomized Control Trial. JAMA 2002; 288: 321–33.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   Mosca L, Collins P, Herrrington DM, et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 499–503.

   OpenUrlFREE Full Text
10. Humphrey LL, Chan BKS, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med 2002; 137: 273–84.

    OpenUrlCrossRefPubMedWeb of Science
11. Majumdar SR, Almasi EA, Stafford RS. Promotion and prescribing of hormone therapy after report of harm by the Women’s Health Initiative. JAMA 2004; 292: 1983–8.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    The Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004; 291: 1701–12.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    Barber CA, Margolis K, Luepker RV, Arnett DK. The impact of the Women’s Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000–2002). J Women’s Health 2004; 13: 975–85.

    OpenUrl
14. ↵
    Ettinger B, Grady D, Tosteson AN, Pressman A, Macer JL. Effect of the Women’s Health Initiative on women’s decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003; 102: 1225–32.

    OpenUrlCrossRefPubMedWeb of Science
15. Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004; 140: 184–8.

    OpenUrlCrossRefPubMedWeb of Science
16. Kliger B. Black cohosh. Am Fam Physician 2003; 68: 114–6.

    OpenUrlPubMed
17. ↵
    Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002; 137: 805–13.

    OpenUrlPubMedWeb of Science
18. ↵
    Freedman RR, Woodward S. Behavioral treatment of menopausal hot flashes: evaluation by ambulatory monitoring. Am J Obstet Gynecol 1992; 167: 436–9.

    OpenUrlPubMedWeb of Science
19. ↵
    Irvin JH, Domar AD, Clark C, Zuttermeister PC, Friedman R. The effects of relaxation response training on menopausal symptoms. J Psychosom Obstet Gynaecol 1996; 17: 202–7.

    OpenUrlPubMed
20. ↵
    Bastian LA, Breslau ES, Davis WW, Moser RP. Hormone therapy for menopausal symptoms: tracking the translation of the Women’s Health Initiative findings. JCOM 2005; 12: 140–6.

    OpenUrl
21. ↵
    NIH State-of-the-Science Panel. National Institutes of Health State-of-the-Science Conference Statement: management of menopause-related symptoms. Ann Intern Med 2005; 142: 1003–13.

    OpenUrlCrossRefPubMed
22. ↵
    U.S. Preventive Services Task Force. Chemoprevention for hormone replacement therapy. Release date: 2002. Available from: http://www.ahcpr.gov/clinic/uspstf/uspspmho.htm